Clinicians have been more and more often encountering patients with venous
thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis, leading …

Background Patients with unprovoked venous thromboembolism (VTE) can be stratified
according to their recurrence risk based on their sex, the VTE location, and d‐dimer …

Background Post‐thrombotic syndrome (PTS) is the most frequent complication of deep vein
thrombosis (DVT). Its diagnosis is based on clinical characteristics. However, symptoms and …

Residual venous obstruction (RVO) could improve the stratification of the risk of recurrence
after unprovoked deep vein thrombosis (DVT), but results from clinical studies and study …

Individualized anticoagulation management and improvement of the safety and
effectiveness of oral anticoagulant have always been the focus of clinicians' attention. D …

Essentials Long‐term recurrence risk after a first unprovoked VTE with negative d‐dimer
levels is uncertain. Anticoagulation was stopped if d‐dimer was negative, and was …

Introduction Prediction models for recurrence and bleeding are infrequently used when
deciding on anticoagulant treatment duration after venous thromboembolism (VTE) due to …

Recurrent venous thromboembolism (VTE) is associated with increased morbidity and
mortality. This risk is lowered by anticoagulation, with a large effect in the initial phase …

Background Recurrent venous thromboembolism (VTE) is common. Current guidelines
suggest that patients with unprovoked VTE should continue anticoagulants unless they have …

Obesity and inflammatory bowel disease (IBD) are systemic inflammatory disorders that
predispose to arterial and venous thrombosis through similar prothrombotic mechanisms …